Atlas Trials

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT01273610 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01273610
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast NeoplasmsHER2/Neu PositiveGeriatric Health Services
Start date
2011-04-20
Primary completion
2018-02-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.